Joshua Brody, MD, discusses the gratification of the crossover between medicine and science at the 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019).
Joshua Brody, MD
Advertisement
Articles by Joshua Brody, MD
Advertisement
Latest Updated Articles
Joshua Brody, MD, on Cross-Section of Science and Medicine at SITC 2019Published: November 12th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
3
What Do Physicians and Patients Think About ADCs as Cancer Treatment?
4
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
5
